Related Experiment Video

Updated: May 21, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Coronary heart disease in men

Michael E Cobble1

  • 1Canyons Medical Center, Adjunct Faculty, University of Utah School of Medicine, Sandy, UT, USA.

The Journal of Family Practice
|June 7, 2012
PubMed

Insights

Managing key cardiovascular risk factors like dyslipidemia and hypertension is crucial for preventing future heart events. This involves medical assessment, lipid management with statins, and combination antihypertensive therapy, alongside lifestyle changes.

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Internal Medicine

Background:

  • Cardiovascular diseases remain a leading cause of morbidity and mortality.
  • Effective management of modifiable risk factors like dyslipidemia and hypertension is essential for primary and secondary prevention.
  • Current guidelines emphasize a multifactorial risk reduction approach.

Purpose of the Study:

  • To outline a comprehensive strategy for assessing and managing cardiovascular risk factors.
  • To highlight the role of lipid-lowering and antihypertensive therapies in reducing cardiovascular events.
  • To emphasize the importance of a multifactorial approach in cardiovascular care for men.

Main Methods:

  • Assessment includes medical history, physical examination, and laboratory tests (lipid profile, glycosylated hemoglobin).
  • Pharmacological management involves statins as first-line therapy for low-density lipoprotein cholesterol (LDL-C) reduction.
  • Antihypertensive therapy often requires combination treatment based on comorbidities and side effects.

Main Results:

  • Statin therapy, potentially high-dose, is effective in achieving target LDL-C levels.
  • Combination antihypertensive therapy is frequently necessary to reach blood pressure goals.
  • A comprehensive approach integrating risk factor modification is key.

Conclusions:

  • Aggressive management of dyslipidemia and hypertension is vital for reducing long-term cardiovascular event risk.
  • Personalized therapeutic strategies, including statins and combination antihypertensives, are crucial.
  • Integrating multifactorial risk reduction, smoking cessation, and lifestyle modifications is fundamental to optimal cardiovascular care for men.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...